Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
The Journal of Applied Laboratory Medicine|October 23, 2019
Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver FibrosisJames Day, Preya Patel, Julie Parkes, et al.Clinical Practice and Cases in Emergency Medicine|November 23, 2021
Bilateral Cranial Nerve VI Palsies in Cryptococcal Meningitis, HIV, and Syphilis: A Case ReportGermaine Rival, Onyi Okorji, Rachael Kern, et al.Alimentary Pharmacology & Therapeutics|June 11, 2024
How effective are experienced hepatologists at staging fibrosis using non-invasive fibrosis tests in patients with metabolic dysfunction-associated steatotic liver disease?Stuart McPherson, Jessica K Dyson, Laura Jopson, et al.Cureus|March 20, 2023
Sarcoid Here, Sarcoid There, Sarcoid EverywherePeter A Iskander, Preya Patel, Ronakkumar Patel, et al.Cancer Medicine|October 7, 2022
Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipientsMamatha Bhat, Elisa Pasini, Preya Patel, et al.BMJ Open Gastroenterology|August 28, 2020
Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis CStuart McPherson, Shion Gosrani, Sarah Hogg, et al.BMJ Open Gastroenterology|March 25, 2021
Association of exercise participation levels with cardiometabolic health and quality of life in individuals with hepatitis CKate Hallsworth, Shion Gosrani, Sarah Hogg, et al.ERJ Open Research|July 13, 2022
Interstitial lung disease incidence and mortality in the UK and the European Union: an observational study, 2001-2017Justin D Salciccioli, Dominic C Marshall, Richard Goodall, et al.BMJ Open|June 5, 2021
Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood testsFreya Alison Rhodes, Sara Cococcia, Preya Patel, et al.Critical Reviews in Oncology/Hematology|March 1, 2022
Underrepresentation of Black participants and adverse events in clinical trials of lenalidomide for myelomaCharles J Milrod, Michael Mann, Frances Blevins, et al.Pageof 2